VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 131 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $502,448 | -35.4% | 64,832 | -4.6% | 0.00% | – |
| Q2 2023 | $778,325 | +88.0% | 67,976 | +26.6% | 0.00% | – |
| Q1 2023 | $414,027 | +23.4% | 53,700 | -2.4% | 0.00% | – |
| Q4 2022 | $335,500 | +2.9% | 55,000 | 0.0% | 0.00% | – |
| Q3 2022 | $326,000 | +0.3% | 55,000 | 0.0% | 0.00% | – |
| Q2 2022 | $325,000 | +10733.3% | 55,000 | +8616.3% | 0.00% | – |
| Q2 2021 | $3,000 | -97.7% | 631 | -97.7% | 0.00% | – |
| Q1 2021 | $128,000 | -65.3% | 27,188 | -47.3% | 0.00% | – |
| Q4 2020 | $369,000 | -58.4% | 51,616 | -37.8% | 0.00% | -100.0% |
| Q3 2020 | $886,000 | +35.5% | 82,998 | +60.1% | 0.00% | – |
| Q2 2020 | $654,000 | +660.5% | 51,842 | +449.9% | 0.00% | – |
| Q1 2020 | $86,000 | -85.3% | 9,428 | -77.6% | 0.00% | – |
| Q4 2019 | $586,000 | +202.1% | 42,079 | +270.9% | 0.00% | – |
| Q3 2019 | $194,000 | -60.4% | 11,345 | -37.2% | 0.00% | – |
| Q2 2019 | $490,000 | +3.4% | 18,052 | -27.4% | 0.00% | – |
| Q1 2019 | $474,000 | -65.5% | 24,869 | -83.0% | 0.00% | -100.0% |
| Q4 2018 | $1,374,000 | -66.0% | 146,233 | -31.6% | 0.00% | 0.0% |
| Q3 2018 | $4,045,000 | +128.3% | 213,893 | +135.7% | 0.00% | 0.0% |
| Q2 2018 | $1,772,000 | -50.4% | 90,755 | -52.3% | 0.00% | -50.0% |
| Q1 2018 | $3,571,000 | +445.2% | 190,140 | +380.2% | 0.00% | – |
| Q4 2017 | $655,000 | +135.6% | 39,596 | +192.5% | 0.00% | – |
| Q3 2017 | $278,000 | +94.4% | 13,536 | -15.6% | 0.00% | – |
| Q2 2017 | $143,000 | +175.0% | 16,031 | +296.4% | 0.00% | – |
| Q1 2017 | $52,000 | -38.8% | 4,044 | -40.6% | 0.00% | – |
| Q4 2016 | $85,000 | +269.6% | 6,803 | +252.5% | 0.00% | – |
| Q3 2016 | $23,000 | +21.1% | 1,930 | +7.5% | 0.00% | – |
| Q2 2016 | $19,000 | +171.4% | 1,795 | +106.1% | 0.00% | – |
| Q1 2016 | $7,000 | -77.4% | 871 | -39.7% | 0.00% | – |
| Q4 2015 | $31,000 | – | 1,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |